Results 191 to 200 of about 61,384 (225)
Some of the next articles are maybe not open access.
2019
Abstract The thrombotic microangioapathy (TMA) syndromes are characterized by concomitant occurrence of severe thrombocytopenia, microangiopathic hemolytic anemia, and ischemic end organ dysfunction often of the kidneys. While several of their features overlap in terms of clinical presentation, the pathophysiology and underlying causes ...
Harpreet Singh +2 more
+4 more sources
Abstract The thrombotic microangioapathy (TMA) syndromes are characterized by concomitant occurrence of severe thrombocytopenia, microangiopathic hemolytic anemia, and ischemic end organ dysfunction often of the kidneys. While several of their features overlap in terms of clinical presentation, the pathophysiology and underlying causes ...
Harpreet Singh +2 more
+4 more sources
Thrombotic Microangiopathy in Cancer
Seminars in Thrombosis and Hemostasis, 2018AbstractThrombotic microangiopathy (TMA) is a rare but often devastating complication of cancer and cancer treatment. The syndrome is defined by thrombocytopenia (i.e., a platelet count of < 150,000/mcL or > 30% decrease from baseline), microangiopathic hemolytic anemia, and some evidence of organ damage.
openaire +3 more sources
Thrombotic Microangiopathies and the Kidney
Advances in Kidney Disease and HealthThrombotic microangiopathy (TMA) is a pathological lesion that occurs due to endothelial injury. It can be seen in a heterogenous group of disorders, typically characterized by microangiopathic hemolytic anemia, thrombocytopenia, and end-organ ischemia. TMA can also be renal limited with no systemic manifestations.
Anuja Java +2 more
openaire +2 more sources
[Thrombotic Microangiopathies].
Deutsche medizinische Wochenschrift (1946), 2018Thrombotic microangiopathies are almost devastating diseases leading to death at high frequency if untreated. They consist of at least five distinct entities, TTP, HUS, aHUS, TMA due to drug interference, systemic disease or post therapy TMA. Around 10 years ago there was only one established therapeutic approach as plasmapheresis. Meanwhile, there are
Jörg, Schubert, Michael, Dechant
openaire +1 more source
Diagnosis and treatment of thrombotic microangiopathy
International Journal of Laboratory Hematology, 2022David Kavanagh, Gemma Thompson
exaly
Prostacyclin and Thrombotic Microangiopathy
Seminars in Thrombosis and Hemostasis, 1980G, Remuzzi +6 more
openaire +2 more sources
Overlap of C3 Glomerulopathy and Thrombotic Microangiopathy: A Case Series
Kidney International Reports, 2023Lilian M P Palma, Sanjeev Sethi
exaly
Thrombotic microangiopathy associated with the hypereosinophilic syndrome
Kidney International, 2005Helen Liapis, Gerald Gleich
exaly